cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.14275634
title: Prescription for astigmatic ametropia revisited

description: ABSTRACT The approach to any refractive condition of the eye with regular astigmatism is more complicated than that for myopia or hyperopia alone. It requires familiarity with the complex images collectively identified as Sturm’s conoid. Fortunately, only three of those play a critical role in the interpretation of ametropia with astigmatism. This manuscript discusses a prescription strategy for ametropias associated with regular astigmatism evolved from those three key images.
DOI: 10.6084/m9.figshare.14275631.v1
title: Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema

description: ABSTRACT Purpose: To assess tomographic ganglion cell complex changes in patients with diabetic macular edema treated with intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF). Methods: We analyzed data from 35 eyes of 35 previously untreated patients in whom diabetic macular edema improved after three loading doses of anti-VEGF injection and who did not receive repeated injections. We recorded spectral domain-optical coherence tomography assessments of ganglion cell complex and central macular thickness at baseline and monthly for three months, and on the sixth and ninth month after treatment. We compared the results with those of the unaffected eyes in the same patients and with those in a control group of patients with diabetic macular edema who were untreated. Results: The mean age of the patients in the treatment group was 60 ± 4.38 years. The foveal thicknesses measured using optical coherence tomography decreased significantly from baseline to the third month post-injection (p&lt;0.05). The mean ganglion cell complex thickness was 115.08 ± 16.72 µm before the first injection and 101.05 ± 12.67 µm after the third injection (p&lt;0.05). The mean ganglion cell complex was 110.04 ± 15.07 µm on the sixth month (p&gt;0.05) and 113.12 ± 11.15 µm on the ninth month (p&gt;0.05). We found a significant difference between the patients and the control group in terms of mean ganglion cell complex thickness on the second- and third-months post-injection (p&lt;0.05). Conclusion: Our study showed that the ganglion cell complex thickness in patients with diabetic macular edema decreased after the anti-VEGF injections. We cannot ascertain whether the ganglion cell complex thickness decreases were due to effects of the anti-VEGF agents or to the natural disease course.
DOI: 10.6084/m9.figshare.14275638
title: A theoretical model for graft punch size calculations to prevent Descemet’s membrane folds following deep anterior lamellar keratoplasty

description: ABSTRACT Purpose: The length of Descemet’s membrane and donor graft sizes in deep anterior lamellar keratoplasty do not match in very steep corneas, which can lead to Descemet’s membrane folds. The aim of this study is to establish a theoretical model for graft size calculations for deep anterior lamellar keratoplasty and evaluate its efficacy for preventing Descemet’s membrane folds. Methods: We calculated the arc diameter of the recipient bed by using the cosine formula and developed a table to aid surgeons in donor punch size selection. To test the usefulness of this formula, we evaluated the development of Descemet’s membrane folds in keratoconus patients with very steep corneas (K &gt;60 D). In group 1, deep anterior lamellar keratoplasty surgeries were performed using graft sizes that were determined based on our model (n=31). In group 2, graft sizes were determined based on the empirical judgment of the surgeon without any formal calculation (n=30). Results: Our theoretical calculations demonstrated that the diameter of donor punch sizes needed to prevent Descemet’s membrane fold increases when the cornea is steeper, or the trephine size is larger. We tested the efficacy of this model on the clinical outcome of deep anterior lamellar keratoplasty. The mean age (28.9 ± 10.1 years vs. 32.8 ± 8.3 years, p=0.11) and preoperative K1 (59.2 ± 9.3 D vs. 58.1 ± 9.4 D, p=0.67), K2 (66.2 ± 6.0 D vs. 65.7 ± 7.4 D, p=0.81), and Km values (62.1 ± 7.7 D vs. 61.8 ± 8.1 D, p=0.88) were similar between the two groups. Three patients developed Descemet’s membrane folds in group 2, and none of the patients developed Descemet’s membrane folds in group 1. These results supported our theo retical calculations. Conclusion: Adjustment of donor graft size based on the calculated arc diameter of the recipient bed reduced the development of Descemet’s membrane folds after deep anterior lamellar keratoplasty in steep corneas.
DOI: 10.6084/m9.figshare.14275634.v1
title: Prescription for astigmatic ametropia revisited

description: ABSTRACT The approach to any refractive condition of the eye with regular astigmatism is more complicated than that for myopia or hyperopia alone. It requires familiarity with the complex images collectively identified as Sturm’s conoid. Fortunately, only three of those play a critical role in the interpretation of ametropia with astigmatism. This manuscript discusses a prescription strategy for ametropias associated with regular astigmatism evolved from those three key images.
DOI: 10.6084/m9.figshare.14275637
title: Ocular blood flow and choroidal thickness changes after carotid artery stenting

description: ABSTRACT Purposes: To evaluate changes in ocular blood flow and subfoveal choroidal thickness in patients with symptomatic carotid artery stenosis after carotid artery stenting. Methods: We included 15 men (mean age, 63.6 ± 9.1 years) with symptomatic carotid artery stenosis and 18 healthy volunteers (all men; mean age, 63.7 ± 5.3 years). All participants underwent detailed ophthalmologic examinations including choroidal thickness measurement using enhanced depth-imaging optic coherence tomography. The patients also underwent posterior ciliary artery blood flow measurements using color Doppler ultrasonography before and after carotid artery stenting. Results: Patients lacked ocular ischemic symptoms. Their peak systolic and end-diastolic velocities increased to 10.1 ± 13.1 (p=0.005) and 3.9 ± 6.3 (p=0.064) cm/s, respectively, after the procedure. Subfoveal choroidal thicknesses were significantly thinner in patients with carotid artery stenosis than those in the healthy controls (p=0.01). But during the first week post-procedure, the subfoveal choroidal thicknesses increased significantly (p=0.04). The peak systolic velocities of the posterior ciliary arteries increased significantly after carotid artery stenting (p=0.005). We found a significant negative correlation between the mean increase in peak systolic velocity values after treatment and the mean preprocedural subfoveal choroidal thickness in the study group (p=0.025, r=-0.617). Conclusions: In patients with carotid artery stenosis, the subfoveal choroid is thinner than that in healthy controls. The subfoveal choroidal thickness increases after carotid artery stenting. Carotid artery stenting treatment increases the blood flow to the posterior ciliary artery, and the preprocedural subfoveal choroidal thickness may be a good predictor of the postprocedural peak systolic velocity of the posterior ciliary artery.
DOI: 10.6084/m9.figshare.14275637.v1
title: Ocular blood flow and choroidal thickness changes after carotid artery stenting

description: ABSTRACT Purposes: To evaluate changes in ocular blood flow and subfoveal choroidal thickness in patients with symptomatic carotid artery stenosis after carotid artery stenting. Methods: We included 15 men (mean age, 63.6 ± 9.1 years) with symptomatic carotid artery stenosis and 18 healthy volunteers (all men; mean age, 63.7 ± 5.3 years). All participants underwent detailed ophthalmologic examinations including choroidal thickness measurement using enhanced depth-imaging optic coherence tomography. The patients also underwent posterior ciliary artery blood flow measurements using color Doppler ultrasonography before and after carotid artery stenting. Results: Patients lacked ocular ischemic symptoms. Their peak systolic and end-diastolic velocities increased to 10.1 ± 13.1 (p=0.005) and 3.9 ± 6.3 (p=0.064) cm/s, respectively, after the procedure. Subfoveal choroidal thicknesses were significantly thinner in patients with carotid artery stenosis than those in the healthy controls (p=0.01). But during the first week post-procedure, the subfoveal choroidal thicknesses increased significantly (p=0.04). The peak systolic velocities of the posterior ciliary arteries increased significantly after carotid artery stenting (p=0.005). We found a significant negative correlation between the mean increase in peak systolic velocity values after treatment and the mean preprocedural subfoveal choroidal thickness in the study group (p=0.025, r=-0.617). Conclusions: In patients with carotid artery stenosis, the subfoveal choroid is thinner than that in healthy controls. The subfoveal choroidal thickness increases after carotid artery stenting. Carotid artery stenting treatment increases the blood flow to the posterior ciliary artery, and the preprocedural subfoveal choroidal thickness may be a good predictor of the postprocedural peak systolic velocity of the posterior ciliary artery.
DOI: 10.6084/m9.figshare.14275641
title: Optical coherence tomography detection of changes in inner retinal and choroidal thicknesses in patients with early retinitis pigmentosa

description: ABSTRACT Purpose: To evaluate the inner retinal and choroidal thicknesses in patients with early retinitis pigmentosa. Methods: We analyzed spectral-domain optical coherence tomography images of 35 retinitis pigmentosa patients and 40 healthy individuals. We measured macular and ganglion cell complex thicknesses. We took choroidal thickness measurements in the subfoveal region and 500, 1,000, and 1,500 mm from the foveal center. Results: Patients with retinitis pigmentosa had significantly thinner macular thicknesses and choroidal thicknesses in all measurements, and their individual ganglion cell complex thickness measurements were lower than those in healthy individuals. The mean ganglion cell complex thickness was significantly lower in patients with retinitis pigmentosa than that in controls. The mean macular thickness was significantly correlated with the mean choroidal and mean ganglion cell complex thicknesses. (We found no correlation between the mean choroidal thickness and the mean ganglion cell complex thickness). Conclusions: The choroid was mildly affected in our patients with early retinitis pigmentosa. The tendency toward significance in the inner retina was possibly caused by a good visual acuity.
DOI: 10.6084/m9.figshare.14275638.v1
title: A theoretical model for graft punch size calculations to prevent Descemet’s membrane folds following deep anterior lamellar keratoplasty

description: ABSTRACT Purpose: The length of Descemet’s membrane and donor graft sizes in deep anterior lamellar keratoplasty do not match in very steep corneas, which can lead to Descemet’s membrane folds. The aim of this study is to establish a theoretical model for graft size calculations for deep anterior lamellar keratoplasty and evaluate its efficacy for preventing Descemet’s membrane folds. Methods: We calculated the arc diameter of the recipient bed by using the cosine formula and developed a table to aid surgeons in donor punch size selection. To test the usefulness of this formula, we evaluated the development of Descemet’s membrane folds in keratoconus patients with very steep corneas (K &gt;60 D). In group 1, deep anterior lamellar keratoplasty surgeries were performed using graft sizes that were determined based on our model (n=31). In group 2, graft sizes were determined based on the empirical judgment of the surgeon without any formal calculation (n=30). Results: Our theoretical calculations demonstrated that the diameter of donor punch sizes needed to prevent Descemet’s membrane fold increases when the cornea is steeper, or the trephine size is larger. We tested the efficacy of this model on the clinical outcome of deep anterior lamellar keratoplasty. The mean age (28.9 ± 10.1 years vs. 32.8 ± 8.3 years, p=0.11) and preoperative K1 (59.2 ± 9.3 D vs. 58.1 ± 9.4 D, p=0.67), K2 (66.2 ± 6.0 D vs. 65.7 ± 7.4 D, p=0.81), and Km values (62.1 ± 7.7 D vs. 61.8 ± 8.1 D, p=0.88) were similar between the two groups. Three patients developed Descemet’s membrane folds in group 2, and none of the patients developed Descemet’s membrane folds in group 1. These results supported our theo retical calculations. Conclusion: Adjustment of donor graft size based on the calculated arc diameter of the recipient bed reduced the development of Descemet’s membrane folds after deep anterior lamellar keratoplasty in steep corneas.
DOI: 10.6084/m9.figshare.14275641.v1
title: Optical coherence tomography detection of changes in inner retinal and choroidal thicknesses in patients with early retinitis pigmentosa

description: ABSTRACT Purpose: To evaluate the inner retinal and choroidal thicknesses in patients with early retinitis pigmentosa. Methods: We analyzed spectral-domain optical coherence tomography images of 35 retinitis pigmentosa patients and 40 healthy individuals. We measured macular and ganglion cell complex thicknesses. We took choroidal thickness measurements in the subfoveal region and 500, 1,000, and 1,500 mm from the foveal center. Results: Patients with retinitis pigmentosa had significantly thinner macular thicknesses and choroidal thicknesses in all measurements, and their individual ganglion cell complex thickness measurements were lower than those in healthy individuals. The mean ganglion cell complex thickness was significantly lower in patients with retinitis pigmentosa than that in controls. The mean macular thickness was significantly correlated with the mean choroidal and mean ganglion cell complex thicknesses. (We found no correlation between the mean choroidal thickness and the mean ganglion cell complex thickness). Conclusions: The choroid was mildly affected in our patients with early retinitis pigmentosa. The tendency toward significance in the inner retina was possibly caused by a good visual acuity.
DOI: 10.6084/m9.figshare.14275643
title: Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study

description: ABSTRACT Purpose: To compare the benefits and side effects of pars plana vitrectomy with those of systemic immune modulator therapy for patients with complicated intermediate uveitis. Methods: This prospective clinical trial enrolled patients with recurrent intermediate uveitis who exhibited minimal improvement of visual acuity, despite injections of periocular steroids. Twenty patients were randomized to the pars plana vitrectomy group or oral steroid and cyclosporine-A group (10 eyes of 10 patients per group). Follow-up was performed for 24 months to study changes in visual acuity, binocular indirect ophthalmoscopy score, fluorescein angiography, and optical coherence tomography findings. Results: Visual acuity (logarithm of the minimal angle of resolution) significantly improved from 0.71 to 0.42 (p=0.001) in the surgical group, whereas it improved from 0.68 to 0.43 (p=0.001) in the immune modulator therapy group. Seven patients (70%) in the surgical group gained ≥2 lines, and six patients (60%) in the immune modulator therapy group gained ≥2 lines (p=0.970). Fluorescein angiography and optical coherence tomography studies showed that six of seven pars plana vitrectomy patients who had cystoid macular edema experienced improvement, whereas two patients with diffuse macular edema did not experience improvement. In the immune modulator therapy group, three of six patients with cystoid macular edema did not experience improvement, whereas two patients with diffuse macular edema experienced improvement. Conclusions: Pars plana vitrectomy and immune modulator therapy resulted in significant improvement in visual function in patients with persistent inflammation secondary to chronic intermediate uveitis. Despite this success, there remains a need for the determination of optimal indications for the use of each modality. Immune modulator therapy was successful for the treatment of diffuse macular edema associated with chronic intermediate uveitis, whereas pars plana vitrectomy was not.
DOI: 10.6084/m9.figshare.14275643.v1
title: Immune modulator therapy compared with vitrectomy for management of complicated intermediate uveitis: a prospective, randomized clinical study

description: ABSTRACT Purpose: To compare the benefits and side effects of pars plana vitrectomy with those of systemic immune modulator therapy for patients with complicated intermediate uveitis. Methods: This prospective clinical trial enrolled patients with recurrent intermediate uveitis who exhibited minimal improvement of visual acuity, despite injections of periocular steroids. Twenty patients were randomized to the pars plana vitrectomy group or oral steroid and cyclosporine-A group (10 eyes of 10 patients per group). Follow-up was performed for 24 months to study changes in visual acuity, binocular indirect ophthalmoscopy score, fluorescein angiography, and optical coherence tomography findings. Results: Visual acuity (logarithm of the minimal angle of resolution) significantly improved from 0.71 to 0.42 (p=0.001) in the surgical group, whereas it improved from 0.68 to 0.43 (p=0.001) in the immune modulator therapy group. Seven patients (70%) in the surgical group gained ≥2 lines, and six patients (60%) in the immune modulator therapy group gained ≥2 lines (p=0.970). Fluorescein angiography and optical coherence tomography studies showed that six of seven pars plana vitrectomy patients who had cystoid macular edema experienced improvement, whereas two patients with diffuse macular edema did not experience improvement. In the immune modulator therapy group, three of six patients with cystoid macular edema did not experience improvement, whereas two patients with diffuse macular edema experienced improvement. Conclusions: Pars plana vitrectomy and immune modulator therapy resulted in significant improvement in visual function in patients with persistent inflammation secondary to chronic intermediate uveitis. Despite this success, there remains a need for the determination of optimal indications for the use of each modality. Immune modulator therapy was successful for the treatment of diffuse macular edema associated with chronic intermediate uveitis, whereas pars plana vitrectomy was not.
DOI: 10.6084/m9.figshare.14275644
title: Ganglion cell layer thinning in diabetic patients without retinopathy: related or unrelated to total macular thickness?

description: ABSTRACT Purpose: Reduction of ganglion cell layer thickness may occur in diabetic patients without retinopathy. The relationships of this preclinical finding with retinal thickness or reduced parafoveal vessel density have not been established. This study investigated the relationships of ganglion cell layer thickness with retinal thickness and parafoveal vessel density in patients with and without diabetes. Methods: This was an observational, cross-sectional, prospective study that used optical coherence tomography angiography to compare non-diabetic patients (group 1) with diabetic patients without retinopathy (group 2). Ganglion cell layer thickness, macular thickness, and parafoveal vessel density (central, inner, and complete) medians were compared between groups (Mann-Whitney U test), and their relationships were assessed in each group (Spearman Rho test). Results: In total, 68 eyes were included in this study: 34 in group 1 and 34 in group 2. Ganglion cell layer thickness did not differ between groups in any sector. There were strong positive correlations between fields 2 (superior parafoveal), 3 (temporal parafoveal), and 4 (inferior parafoveal) of the optical coherence tomography macular thickness map and the ganglion cell layer thickness in all sectors in both groups. Central vessel density mean was lower in diabetic patients. In group 1 alone, thickness changes in the inferior and nasal inferior ganglion cell layer sectors were partially explained by inner vessel density (r2=0.32 and r2=0.27). Conclusions: Mean ganglion cell layer thickness was not lower in diabetic patients without retinopathy than in non-diabetic patients. Moreover, it exhibited a substantial correlation with total macular thickness. Parafoveal vessel density decreased before ganglion cell layer thinning was observed.
DOI: 10.6084/m9.figshare.14275644.v1
title: Ganglion cell layer thinning in diabetic patients without retinopathy: related or unrelated to total macular thickness?

description: ABSTRACT Purpose: Reduction of ganglion cell layer thickness may occur in diabetic patients without retinopathy. The relationships of this preclinical finding with retinal thickness or reduced parafoveal vessel density have not been established. This study investigated the relationships of ganglion cell layer thickness with retinal thickness and parafoveal vessel density in patients with and without diabetes. Methods: This was an observational, cross-sectional, prospective study that used optical coherence tomography angiography to compare non-diabetic patients (group 1) with diabetic patients without retinopathy (group 2). Ganglion cell layer thickness, macular thickness, and parafoveal vessel density (central, inner, and complete) medians were compared between groups (Mann-Whitney U test), and their relationships were assessed in each group (Spearman Rho test). Results: In total, 68 eyes were included in this study: 34 in group 1 and 34 in group 2. Ganglion cell layer thickness did not differ between groups in any sector. There were strong positive correlations between fields 2 (superior parafoveal), 3 (temporal parafoveal), and 4 (inferior parafoveal) of the optical coherence tomography macular thickness map and the ganglion cell layer thickness in all sectors in both groups. Central vessel density mean was lower in diabetic patients. In group 1 alone, thickness changes in the inferior and nasal inferior ganglion cell layer sectors were partially explained by inner vessel density (r2=0.32 and r2=0.27). Conclusions: Mean ganglion cell layer thickness was not lower in diabetic patients without retinopathy than in non-diabetic patients. Moreover, it exhibited a substantial correlation with total macular thickness. Parafoveal vessel density decreased before ganglion cell layer thinning was observed.